Chargement en cours...
Single‐pill combination of cilnidipine, an l‐/n‐type calcium channel blocker, and valsartan reduces the day‐by‐day variability of morning home systolic blood pressure in patients with treated hypertension: A sub‐analysis of the HOPE‐combi survey
We examined the effects of a fixed‐dose single‐pill combination of cilnidipine (10 mg), an L‐/N‐type calcium channel blocker, and valsartan (80 mg) (SPC of Cil/Val) on the day‐by‐day variability of morning home systolic blood pressure (MHSBP) in 616 patients with treated hypertension for 12 months a...
Enregistré dans:
| Publié dans: | J Clin Hypertens (Greenwich) |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8029779/ https://ncbi.nlm.nih.gov/pubmed/33455076 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jch.14178 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|